OGC
Oak Grove Capital’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Sell |
3,194
-8,885
| -74% | -$3.6M | 0.21% | 38 |
|
|
2025
Q1 | $6.01M | Sell |
12,079
-256
| -2% | -$127K | 1.25% | 17 |
|
|
2024
Q4 | $6.42M | Sell |
12,335
-4
| -0% | -$2.08K | 0.96% | 20 |
|
|
2024
Q3 | $7.63M | Buy |
12,339
+6
| +0% | +$3.71K | 1.25% | 15 |
|
|
2024
Q2 | $6.82M | Sell |
12,333
-300
| -2% | -$166K | 1.24% | 14 |
|
|
2024
Q1 | $7.34M | Sell |
12,633
-100
| -0.8% | -$58.1K | 1.48% | 15 |
|
|
2023
Q4 | $6.76M | Buy |
12,733
+1,000
| +9% | +$531K | 1.8% | 16 |
|
|
2023
Q3 | $5.94M | Sell |
11,733
-100
| -0.8% | -$50.6K | 2.06% | 15 |
|
|
2023
Q2 | $6.17M | Buy |
11,833
+1,360
| +13% | +$710K | 2.11% | 15 |
|
|
2023
Q1 | $6.04M | Buy |
10,473
+146
| +1% | +$84.2K | 2.47% | 12 |
|
|
2022
Q4 | $5.69M | Sell |
10,327
-1,525
| -13% | -$840K | 2.86% | 12 |
|
|
2022
Q3 | $6.01M | Buy |
11,852
+2,360
| +25% | +$1.2M | 2.03% | 15 |
|
|
2022
Q2 | $5.16M | Sell |
9,492
-620
| -6% | -$337K | 1.68% | 18 |
|
|
2022
Q1 | $5.97M | Buy |
10,112
+50
| +0.5% | +$29.5K | 1.21% | 23 |
|
|
2021
Q4 | $6.71M | Sell |
10,062
-193
| -2% | -$129K | 1.17% | 21 |
|
|
2021
Q3 | $5.86M | Sell |
10,255
-50
| -0.5% | -$28.6K | 1.26% | 22 |
|
|
2021
Q2 | $5.2M | Buy |
10,305
+550
| +6% | +$277K | 1.16% | 24 |
|
|
2021
Q1 | $4.45M | Sell |
9,755
-150
| -2% | -$68.5K | 1.24% | 28 |
|
|
2020
Q4 | $4.61M | Buy |
9,905
+3,015
| +44% | +$1.4M | 1.51% | 25 |
|
|
2020
Q3 | $3.04M | Sell |
6,890
-90
| -1% | -$39.7K | 1.44% | 24 |
|
|
2020
Q2 | $2.53M | Buy |
+6,980
| New | +$2.53M | 1.52% | 19 |
|